Application of SW-LIMS in the Confidentiality of Drug Inspection and Testing

2026-01-21 11:20:34

Application of SW-LIMS in the Confidentiality of Drug Inspection and Testing

Confidentiality in drug inspection and testing refers to the principles and measures for the confidentiality and protection of information involved in the process of drug inspection and testing. As a crucial measure to ensure drug quality and safety, it mainly includes the following aspects:
1. Data Protection
Data generated during drug inspection and testing shall be encrypted and stored to ensure that only authorized personnel can access and use such data. Meanwhile, measures shall be taken to prevent data leakage and illegal access.
2. Sample Protection
Samples for drug inspection and testing shall be protected during collection, transportation and storage to prevent tampering, contamination or replacement. Only authorized personnel are allowed to contact and handle the samples.
3. Information Sharing Control
The scope of sharing information involved in drug inspection and testing shall be strictly controlled, and only authorized personnel can share relevant information. In the meantime, corresponding security mechanisms shall be established to ensure the safety and reliability of information sharing.
4. Staff Confidentiality
Personnel engaged in drug inspection and testing shall sign confidentiality agreements and receive relevant confidentiality training to ensure they understand and comply with confidentiality regulations. Additionally, a supervision mechanism shall be established to supervise and inspect the confidentiality behaviors of staff.
Confidentiality in drug inspection and testing is of great significance to inspection institutions. For example, in terms of protecting enterprises' commercial interests: drug test results may involve commercial interests of pharmaceutical manufacturers, including product quality, ingredients, efficacy and other information. If such information is leaked, competitors may obtain commercial secrets, resulting in losses to the enterprises.
Another example is the protection of patients' privacy: drug testing may also involve patients' personal information, such as medical records and medication history. The leakage of such information may infringe on patients' right to privacy and even lead to the abuse of personal information. Therefore, inspection and testing institutions need to adopt a series of technical and management measures to protect the security of relevant information and samples.
In view of the above situation, Beijing Sunway World Technology Co., Ltd. has independently developed the Laboratory Information Management System (SW-LIMS). In terms of product functions, it can flexibly set the display of sample information at each process node. For instance, display fields can be customized in links such as sample registration and acceptance, sample retention management, task assignment, inspection and testing, proofreading, report issuance, and report distribution.
By displaying the information fields concerned by authorized personnel at each node according to different process nodes, it can effectively ensure the confidentiality of inspection and testing data fields at different nodes. Meanwhile, it provides authorized personnel with quick list export and advanced query functions, facilitating them to screen, query and export data during the approval process and improving the efficiency of inspection work.
While realizing the customized display of process node field data, SW-LIMS has also developed the report function of the "Custom Query Module", providing personalized statistical analysis functions for data confidentiality at the application level of data statistical analysis. System administrators can conveniently generate statistical data report menus required for business through this module without updating background applications, and quickly generate report menu functions through front-end page configuration.

The main features of this function are as follows:
1.Both the fields displayed in report statistics and the setting of query conditions can be flexibly configured, enhancing the convenience for authorized personnel to conduct data statistics.
2.Menu functions are controlled by associating with roles to achieve the isolation of data and permissions, so that different authorized personnel can focus on different information and data.
3.Relevant authorized personnel can conduct multi-dimensional and flexible combination of filter conditions for data query, statistics and analysis according to the fields assigned by authorization, improving the extensibility of report queries.

In SW-LIMS, different data and permissions are separated and isolated, which can effectively protect the data security in the system, prevent the leakage and abuse of basic sample information and test results, and ensure that authorized users can only access the data and functions they are authorized to use. This improves the security and credibility of the system, so as to protect the confidentiality of sample information and data.
Through the customized data statistical analysis function module, SW-LIMS can quickly and efficiently provide the required data statistics for each authorized person, offering data support for business decision-making. SW-LIMS integrates data statistics with information confidentiality, ensuring the confidentiality of data information and test results while sharing data in the information system.
SW-LIMS provides a strong guarantee for strengthening laboratory information security management, the confidentiality of drug inspection and testing, and drug quality and safety, thus protecting the legitimate rights and interests of pharmaceutical manufacturers and consumers. As a well-known laboratory information management platform in China, SW-LIMS has been committed to providing customers with better services. It will continue to develop and improve product functions, strive to bring a better experience to users, and look forward to establishing strong cooperation with you for win-win results in the future.